Literature DB >> 6690076

Do cells of continually renewing populations and those stimulated from quiescence respond similarly to HU and Ara-C?

H P Benton, M R Alison.   

Abstract

The cytocidal and cytostatic effects of a single dose of either hydroxyurea (HU) or cytosine arabinoside (Ara-C) have been studied in a variety of tissues, from both rats and mice, by autoradiographic and histological methods. The necrogenic effects of the drugs on DNA-synthesising cells from continually renewing populations have been compared with the effects on cells induced to enter DNA synthesis from a formerly quiescent state. Four models of stimulated proliferation have been studied; the isoprenaline-stimulated salivary glands, the testosterone-stimulated seminal vesicle in the castrate, the regenerating liver after two-thirds partial hepatectomy, and a model of diethylnitrosamine (DEN)-induced hepatocyte proliferation. The time course of the cytokinetic response in each tissue was followed for a period of 24 h after drug treatment. The cytostatic effects of the drugs were similar in all tissues investigated, DNA synthesis being inhibited for a 4- to 5-h period. However, the sensitivity to the lethal effects showed both tissue and species variability.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690076     DOI: 10.1007/bf00255911

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  18 in total

1.  Inhibition of ribonucleoside diphosphate reductase by hydroxyurea.

Authors:  I H Krakoff; N C Brown; P Reichard
Journal:  Cancer Res       Date:  1968-08       Impact factor: 12.701

2.  Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.

Authors:  D H Ho; E Frei
Journal:  Clin Pharmacol Ther       Date:  1971 Nov-Dec       Impact factor: 6.875

3.  Differential effects of hydroxyurea on survival of proliferating cells in vivo.

Authors:  E Farber; R Baserga
Journal:  Cancer Res       Date:  1969-01       Impact factor: 12.701

4.  Stimulation of DNA synthesis by isoproterenol in the salivary gland.

Authors:  T Barka
Journal:  Exp Cell Res       Date:  1965-09       Impact factor: 3.905

5.  Different sensitivity of chromatin to acid denaturation in quiescent and cycling cells as revealed by flow cytometry.

Authors:  Z Darzynkiewicz; F Traganos; M Andreeff; T Sharpless; M R Melamed
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

6.  Androgen priming and cytotoxic chemotherapy in advanced prostatic cancer.

Authors:  A J Suarez; D L Lamm; H M Radwin; M Sarosdy; G Clark; C K Osborne
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

8.  Growth fraction and cycle duration of hepatocytes in the three-week-old rat.

Authors:  B Schultze; A M Kellerer; C Grossmann; W Maurer
Journal:  Cell Tissue Kinet       Date:  1978-05

9.  The proliferation response of rat liver parenchymal cells after partial hepatectomy. A methodological study comparing flow cytometry of nuclear DNA content and in vivo and in vitro uptake of thymidine.

Authors:  V Digernes; G Brønstad; T E Sand; T Christoffersen
Journal:  Cell Tissue Kinet       Date:  1982-09

10.  The kinetics of cellular proliferation in regenerating liver.

Authors:  J I Fabrikant
Journal:  J Cell Biol       Date:  1968-03       Impact factor: 10.539

View more
  2 in total

1.  The nature of cytotoxic drug-induced cell death in murine intestinal crypts.

Authors:  T V Anilkumar; C E Sarraf; T Hunt; M R Alison
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

2.  Bromodeoxyuridine-labelled apoptosis after treatment with antimetabolites in two murine tumours and in small intestinal crypts.

Authors:  C E Sarraf; T W Ansari; P Conway; M Notay; S Hill; M R Alison
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.